Potential for false negative diagnosis of gastroparesis. Certain GEBT kits containing 13C-Spirulina elicit unusually high 13CO2-excretion rates
Source facts
Action
The firm initiated the recall by telephone or email, followed with a telephone call on 01/08/2021. Commercial clients have been instructed not to use GEBT kits and that Cairn will follow up with a recall notice with full instructions on what to do with kits.
Initiated
2021-01-08
Root cause
Under Investigation by firm
Terminated
2023-08-09
Distribution
US Nationwide distribution in the states of GA, NY, MI, CA, KS, NC.
Recall number
Z-1128-2021
Recall status
Terminated
CDRH record ID
185506
FDA record created
2021-02-16
Recall event number
87186
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.